Tokyo, Japan

Manabu Kawada


 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Numazu, JP (2012)
  • Tokyo, JP (2016 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Manabu Kawada: Innovator in Anti-Cancer Compounds

Introduction

Manabu Kawada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. With a total of five patents to his name, Kawada's work is recognized for its innovative approach to combating cancer.

Latest Patents

Kawada's latest patents include a novel compound, its production method, and its use in pharmaceutical compositions. One of his key applications provides details on compounds that exhibit anti-cancer activity. This application outlines methods for producing these compounds and their potential uses in medical treatments. Another patent focuses on a compound defined by specific structural formulas, detailing its production and applications as an anti-cancer agent.

Career Highlights

Throughout his career, Manabu Kawada has worked with notable organizations such as the Microbial Chemistry Research Foundation and Medical & Biological Laboratories Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to significant developments in the pharmaceutical industry.

Collaborations

Kawada has collaborated with esteemed colleagues, including Hiroyuki Inoue and Hikaru Abe. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of anti-cancer compounds.

Conclusion

Manabu Kawada's contributions to the development of anti-cancer compounds highlight his role as a leading inventor in the pharmaceutical industry. His innovative patents and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…